CHD les Oudaries

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials
• Mesothelioma1 trial

Phase

• Phase 21 trial

Status

• Completed1 trial
• Not yet recruiting1 trial

Lead sponsor

• Groupe Francais De Pneumo-Cancerologie2 trials

Running trials

• Recruiting

  Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib

  NCT06620835· Phase 2· Groupe Francais De Pneumo-Cancerologie· Source

  Contact: Marie MARCQ

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer1 recruiting

Closed trials

• Completed

  Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE)

  NCT05308966· Groupe Francais De Pneumo-Cancerologie· Source